Kentucky Retirement Systems Insurance Trust Fund lowered its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 7.1% during the third quarter, Holdings Channel reports. The fund owned 2,126 shares of the biotechnology company’s stock after selling 162 shares during the quarter. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Axon Enterprise were worth $850,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Blue Trust Inc. boosted its holdings in shares of Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after purchasing an additional 79 shares during the last quarter. Quent Capital LLC grew its holdings in Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares during the period. Asset Dedication LLC acquired a new position in shares of Axon Enterprise during the 2nd quarter valued at about $47,000. Planning Capital Management Corp lifted its holdings in shares of Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after acquiring an additional 55 shares during the period. Finally, Friedenthal Financial acquired a new stake in shares of Axon Enterprise in the third quarter worth approximately $51,000. 79.08% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of equities analysts have weighed in on AXON shares. Craig Hallum increased their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Needham & Company LLC lifted their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Northland Securities upped their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Barclays lifted their price objective on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Finally, Robert W. Baird increased their target price on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $427.83.
Insider Buying and Selling
In other Axon Enterprise news, CEO Patrick W. Smith sold 80,300 shares of Axon Enterprise stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the completion of the transaction, the chief executive officer now owns 3,015,366 shares of the company’s stock, valued at $1,121,052,771.48. The trade was a 2.59 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Brittany Bagley sold 4,338 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the sale, the chief financial officer now directly owns 98,825 shares in the company, valued at $37,449,733.75. This trade represents a 4.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 411,006 shares of company stock worth $161,360,618. Insiders own 6.10% of the company’s stock.
Axon Enterprise Price Performance
Shares of NASDAQ AXON opened at $599.35 on Monday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a fifty-two week low of $220.78 and a fifty-two week high of $624.84. The business has a 50 day moving average price of $438.79 and a two-hundred day moving average price of $357.90. The firm has a market cap of $45.70 billion, a PE ratio of 154.87, a price-to-earnings-growth ratio of 15.05 and a beta of 0.94.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
- Five stocks we like better than Axon Enterprise
- What is Forex and How Does it Work?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- 5 Top Rated Dividend Stocks to Consider
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What Are Dividend Contenders? Investing in Dividend Contenders
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.